Journal of Chinese Integrative Medicine ›› 2008, Vol. 6 ›› Issue (5): 458-462.doi: 10.3736/jcim20080505
• Review • Previous Articles Next Articles
CLC Number:
| [1] | Hoffman BJ.Sensitivity of sulfadiazine resembling acute disseminated lupus erythematosus[J].Arch Dermatol Syph, 1945, 51: 190-192 |
| [2] |
Puttini P, Atzeni F, Capsoni F , et al. Drug-induced lupus erythematosus[J]. Autoimmunity, 2005,38(7):507-518
doi: 10.1080/08916930500285857 |
| [3] |
Kale SA . Drug-induced systemic lupus erythematosus. Differentiating it from the real thing[J]. Postgrad Med, 1985,77(3):231-235
pmid: 2866863 |
| [4] | Atzeni F, Marrazza MG, Sarzi-Puttini P , et al. Drug-induced lupus erythematosus[J]. Reumatismo, 2003,55(3):147-154 |
| [5] |
Mansilla-Tinoco R, Harland SJ, Ryan PJ , et al. Hydralazine, antinuclear antibodies, and the lupus syndrome[J]. Br Med J (Clin Res Ed), 1982,284(6320):936-939
doi: 10.1136/bmj.284.6320.936 pmid: 6802356 |
| [6] |
Batchelor JR, Welsh KI, Tinoco RM , et al. Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility[J]. Lancet, 1980,1(8178):1107-1109
doi: 10.1016/S0140-6736(80)91554-8 pmid: 6103441 |
| [7] |
Gunnarsson I, Nordmark B, Hassan Bakri A , et al. Development of lupus-related side-effects in patients with early RA during sulphasalazine treatment——the role of IL-10 and HLA[J]. Rheumatology (Oxford), 2000,39(8):886-893
doi: 10.1093/rheumatology/39.8.886 |
| [8] | Speirs C, Fielder AH, Chapel H , et al. Complement system protein C4 and susceptibility to hydralazine-induced systemic lupus erythematosus[J]. Lancet, 1989,1(88644):922-924 |
| [9] |
Totoritis MC, Tan EM , McNally EM, et al.Association of antibody to histone complex H2A-H2B with symptomatic procainamide-induced lupus[J]. N Engl J Med, 1988,318(22):1431-1436
doi: 10.1056/NEJM198806023182204 |
| [10] |
Peterson LL . Hydralazine-induced systemic lupus erythematosus presenting as pyoderma gangrenosum-like ulcers[J]. J Am Acad Dermatol, 1984,10(2 Pt 2):379-384
doi: 10.1016/S0190-9622(84)80011-0 |
| [11] |
Elkayam O, Yaron M, Caspi D . Minocycline-induced autoimmune syndromes: an overvie[J]. Semin Arthritis Rheum, 1999,28(6):392-397
doi: 10.1016/S0049-0172(99)80004-3 |
| [12] |
Sturkenboom MC, Meier CR, Jick H , et al. Minocycline and lupuslike syndrome in acne patients[J]. Arch Intern Med, 1999,159(5):493-497
doi: 10.1001/archinte.159.5.493 |
| [13] |
Gough A, Chapman S, Wagstaff K , et al. Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome[J]. BMJ, 1996,312(7024):169-172
doi: 10.1136/bmj.312.7024.169 pmid: 2349841 |
| [14] |
Khattak FH, Morris IM, Mattingly PC . Sulphasalazine-induced systemic lupus erythematosus in a patient with rheumatoid arthritis[J]. Br J Rheumatol, 1996,35(1):104
doi: 10.1093/rheumatology/35.1.104 pmid: 8624617 |
| [15] |
Gordon MM, Porter DR, Capell HA . Does sulphasalazine cause drug induced systemic lupus erythematosus? No effect evident in a prospective randomised trial of 200 rheumatoid patients treated with sulphasalazine or auranofin over five years[J]. Ann Rheum Dis, 1999,58(5):288-290
doi: 10.1136/ard.58.5.288 |
| [16] |
Walshe JM . Penicillamine and the SLE syndrome[J]. J Rheumatol Suppl, 1981,( 7):155-160
pmid: 6939878 |
| [17] |
Spiera RF, Berman RS, Werner AJ , et al. Ticlopidine-induced lupus: a report of 4 cases[J]. Arch Intern Med, 2002,162(19):2240-2243
doi: 10.1001/archinte.162.19.2240 |
| [18] |
Fenniche S, Dhaoui A, Ammar FB , et al. Acebutolol-induced subacute cutaneous lupus erythematosus[J]. Skin Pharmacol Physiol, 2005,18(5):230-233
doi: 10.1159/000086668 |
| [19] |
Carter JD, Valeriano-Marcet J, Kanik KS , et al. Antinuclear antibody-negative, drug-induced lupus caused by lisinopril[J]. South Med J, 2001,94(11):1122-1123
doi: 10.1097/00007611-200111000-00017 pmid: 11780682 |
| [20] |
Graziadei IW, Obermoser GE, Sepp NT , et al. Drug-induced lupus-like syndrome associated with severe autoimmune hepatitis[J]. Lupus, 2003,12(5):409-412
doi: 10.1191/0961203303lu313cr |
| [21] |
Borchers AT, Keen CL, Gershwin ME . Drug-induced lupus[J]. Ann N Y Acad Sci, 2007,1108(5):166-182
doi: 10.1196/annals.1422.019 |
| [22] |
Uetrecht J . Current trends in drug-induced autoimmunity[J]. Autoimmun Rev, 2005,4(5):309-314
doi: 10.1016/j.autrev.2005.01.002 pmid: 15990079 |
| [23] |
Griem P, Wulferink M, Sachs B , et al. Allergic and autoimmune reactions to xenobiotics: how do they arise?[J]. Immunol Today, 1998,19(3):133-141
doi: 10.1016/S0167-5699(98)80012-1 pmid: 9540273 |
| [24] | Pirmohamed M, Williams DP, Naisbitt DJ , et al. Induction of metabolism-dependent and -independent neutrophil apoptosis by clozapine[J]. Mol Pharmacol, 2000,58(1):133-141 |
| [25] |
Hess DA, Sisson ME, Suria H , et al. Cytotoxicity of sulfonamide reactive metabolites: apoptosis and selective toxicity of CD8(+) cells by the hydroxylamine of sulfamethoxazole[J]. FASEB J, 1999,13(13):1688-1698
doi: 10.1096/fasebj.13.13.1688 |
| [26] | Yung RL, Quddus J, Chrisp CE , et al. Mechanism of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo[J]. J Immunol, 1995,154(6):3025-3035 |
| [27] |
Kretz-Rommel A, Duncan SR, Rubin RL . Autoimmunity caused by disrution of central T cell tolerance. A murine model of drug-induced lupus[J]. J Clin Invest, 1997,99(8):1888-1896
doi: 10.1172/JCI119356 |
| [28] |
Kretz-Rommel A, Rubin RL . Disruption of positive selection of thymocytes causes autoimmunity[J]. Nat Med, 2000,6(3):298-305
doi: 10.1038/73152 pmid: 10700232 |
| [29] | van Rijthoven AW, van Roon JA . Drug-induced systemic lupus erythematosus: reports to The Netherlands Pharmacovigilance Centre Lareb[J]. Ned Tijdschr Geneeskd. 2007, 2007,151(14):839 |
| [30] | Ye RG. Integrated traditional Chinese and Western nephrology.[J]. Beijing: People's Medical Publishing House, 2003,151(14):261 |
| 叶任高 . 中西医结合肾脏病学[J].北京: 人民卫生出版社, 2003,151(14):261 |
| [1] | Zhao-lan Liu, Qing Li , Yu-jie Mu , Ying Gao, Jian-ping Liu. Using nested case-control study to appraise the effectiveness of Chinese medicines in the treatment of diabetic nephropathy. Journal of Chinese Integrative Medicine, 2012, 10(9): 991-996. |
| [2] | Thomas Efferth, Henry Johannes Greten. The European directive on traditional herbal medicinal products: friend or foe for plant-based therapies?. Journal of Chinese Integrative Medicine, 2012, 10(4): 357-361. |
| [3] | Bao Yan-ju, Hua Bao-jin. Discussion on six errors of formulas corresponding to syndromes in using the classic formulas. Journal of Chinese Integrative Medicine, 2012, 10(12): 1363-1370. |
| [4] | Agung E. Nugroho, Adam Hermawan, Dyaningtyas D. P. Putri, E. dY Meiyanto, Lukman Hakim . Synergistic effects of ethyl acetate fraction of Ficus septica Burm. f. and doxorubicin chemotherapy on T47D human breast cancer cell line. Journal of Chinese Integrative Medicine, 2012, 10(10): 1162-1170. |
| [5] | Jie-ning Wang, Sheng Ye, Dong-hai Yu, Hui Zhao, Le-yi Du. Practice and exploration on clinical evaluations of hospital-made Chinese herbal formulas in the Pudong New Area of Shanghai. Journal of Chinese Integrative Medicine, 2012, 10(10): 1084-1087. |
| [6] | Hao Dai, Jun Gu, Ling-zhi Li, Li-mei Yang, Hui Liu, Jian-yu Li. Scutellarin benzyl ester partially secured the ischemic injury by its anti-apoptosis mechanism in cardiomyocytes of neonatal rats. Journal of Chinese Integrative Medicine, 2011, 9(9): 1014-1021. |
| [7] | Wen Sun, Zhi Zhu, Jian Yu, Yong-hong Wang, Man Xiong, Xia Gao, Zhong-hua Zhao, Xue-guang Liu. Effects of Chinese herbal medicine Huaiqihuang Granule on nephrin and podocin expressions in renal tissues of rats with adriamycin-induced nephrosis. Journal of Chinese Integrative Medicine, 2011, 9(5): 546-552. |
| [8] | Liang-ping Hu, Xiao-lei Bao. General issues and precautions in the design for clinical trials of investigational new drugs. Journal of Chinese Integrative Medicine, 2011, 9(2): 138-142. |
| [9] | Qi-lin Fu, Yi-yang Hu, Qin Feng, Xiao-ning Wang, Jing-hua Peng, Tuan Cui. Analysis of major herbs in Chinese herbal formula Jianpi Huoxue Decoction for improving intestinal permeability based on uniform design. Journal of Chinese Integrative Medicine, 2011, 9(11): 1234-1241. |
| [10] | Yan-liYou, Ying-lu Feng, Qing Cai, Jian-long Guan, Lan-ling Zhang, Mei-juan Xu, Xia Xu , Chang-quan Ling . Efficacy of ginsenosides combined with prednisone in patients with systemic lupus erythematosus: a prospective, randomized, double-blind, placebo-controlled trial. Journal of Chinese Integrative Medicine, 2010, 8(8): 762-766. |
| [11] | Feng Tian , Yan-ming Xie. Real-world study: A potential new approach to effectiveness evaluation of traditional Chinese medicine interventions. Journal of Chinese Integrative Medicine, 2010, 8(4): 301-306. |
| [12] | Zhu-ye Gao, Jing-chun Zhang, Hao Xu, Da-zhuo Shi, Chang-geng Fu, Dan Qu, Xue-zhong Zhou. Analysis of relationships among syndrome, therapeutic treatment, and Chinese herbal medicine in patients with coronary artery disease based on complex networks. Journal of Chinese Integrative Medicine, 2010, 8(3): 238-243. |
| [13] | Yan Wang , Li-wu Lin, Zhi-kui Chen, En-sheng Xue, Xiao-dong Lin, Li-yun Yu, Zhen-hu Lin. Effects of intratumoral injection of microspheres containing cobra venom cytotoxin on transplanted human hepatoma in nude mice. Journal of Chinese Integrative Medicine, 2009, 7(9): 836-841. |
| [14] | Qing Lin , Jian Zheng, Si Ai, Li-xing Lin, Yu-xin Chen, Fang Wang, Ling Zhu . Mechanism of combined treatment with Shenkangling Decoction and prednisone in rats with adriamycin-induced nephropathy. Journal of Chinese Integrative Medicine, 2009, 7(7): 661-666. |
| [15] | Jun-chao Chen, Lu-jin Li, Shi-mei Wen, Ying-chun He, Hong-xia Liu, Qing-shan Zheng. Anti-inflammatory effects and quantitative study of the combinations of active ingredients of Painong powder in mice. Journal of Chinese Integrative Medicine, 2009, 7(6): 541-545. |
|